Literature DB >> 3753356

A conceptual model for predicting pilot group G tolerance for tactical fighter aircraft.

R R Burton.   

Abstract

A static model based on eye-heart vertical distance has been developed which predicts group mean G tolerances relative to the application of any of the following anti-G methods and/or physiologic responses: a) anti-G suit, b) reclined seat, c) anti-G straining maneuver (AGSM), d) positive pressure breathing (PPB), e) gradual onset of G, f) isometric muscular contraction, and g) leg elevation. This model was validated with published data. A variation of this model (derived equation) predicts the amount of AGSM (in mm Hg) required, in combination with any of the anti-G methods/responses at any G level. This calculated effort of AGSM can be equated to level of fatigue and performance decrements. A level of 50 mm Hg or an increase of 2 G in the upright seat was the maximum AGSM recommended for routine use as an anti-G method for operational fighter pilots.

Entities:  

Mesh:

Year:  1986        PMID: 3753356

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  4 in total

1.  Chronology of the push pull effect on nonhuman primates-shift of the arterial pressure threshold.

Authors:  Anne I Guillaume; Jean-Dominique Singland; Véronique Chastres
Journal:  Eur J Appl Physiol       Date:  2005-07-20       Impact factor: 3.078

2.  The +Gz recovery of consciousness curve.

Authors:  Typ Whinnery; Estrella M Forster; Paul B Rogers
Journal:  Extrem Physiol Med       Date:  2014-05-02

3.  Combined effect of heart rate responses and the anti-G straining manoeuvre effectiveness on G tolerance in a human centrifuge.

Authors:  Min-Yu Tu; Hsin Chu; You-Jin Lin; Kwo-Tsao Chiang; Chuan-Mu Chen; Hsin-Hui Chen; Chen-Shu Yang; Chung-Yu Lai
Journal:  Sci Rep       Date:  2020-12-10       Impact factor: 4.379

4.  The +Gz-induced loss of consciousness curve.

Authors:  Typ Whinnery; Estrella M Forster
Journal:  Extrem Physiol Med       Date:  2013-06-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.